Lynelle Hoch

BMY

Lynelle Hoch serves as President, Cell Therapy Org. at Bristol-Myers Squibb Company (BMY). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$212.2K

Net Position

Net Seller

$212.2K

Companies Traded

BMY

Active Period

Mar 2024 – Mar 2025

2 total trades

Most Recent

Sell BMY

Mar 12, 2025 · $141.9K

Lynelle Hoch's Insider Trading at Bristol-Myers Squibb Company (BMY)

Buys

0 · $0.00

Sells

2 · $212.2K

Total Shares Bought

Total Shares Sold

3,556

BMY Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 12, 2025↗	Sell	2,248	$63.11	$141.9K	0
Mar 10, 2024↗	Sell	1,308	$53.79	$70.4K	0

Related Insiders

Benjamin Hickey

President, RayzeBio Org.

BMYSell · Feb 1, 2026

Gregory Scott Meyers

EVP, Chief Digital & Tech Off.

BMYSell · Feb 1, 2026

Karin Shanahan

EVP, Chief Supply Chain & Ops

BMYSell · Nov 1, 2025

BOERNER CHRISTOPHER S.

Chief Executive Officer

BMYSell · Nov 1, 2025

Cari Gallman

EVP, General Counsel

BMYSell · Oct 2, 2025

David Elkins V

EVP, Chief Financial Officer

BMYSell · Sep 2, 2025

Bartie Wendy Short

EVP, Corporate Affairs

BMYSell · Sep 1, 2025

Samit Hirawat

EVP,Chief Med.Offr.,Drug Dev.

BMYBuy · Apr 25, 2025

Explore More Insider Trading Data

BMY Insider Trading Activity

View all insider trades at Bristol-Myers Squibb Company

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity